Ignite Creation Date:
2024-05-06 @ 5:57 PM
Last Modification Date:
2024-10-26 @ 2:39 PM
Study NCT ID:
NCT05493631
Status:
RECRUITING
Last Update Posted:
2022-08-25
First Post:
2022-07-21
Brief Title:
A Phase 1b Study to Assess the Safety Tolerability PK and PD of MG1113 in Hemophilia Patient
Sponsor:
GC Biopharma Corp
Organization:
GC Biopharma Corp
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-24
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-07-21
First Submit QC Date:
August 7 2022
Study First Post Date:
2022-08-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-24
Last Update Post Date:
2022-08-25
Last Update Post Date Type:
ACTUAL